FEVER AND ASSOCIATED CHANGES IN GLOMERULAR-FILTRATION RATE ERASE ANTICIPATED DIURNAL-VARIATIONS IN AMINOGLYCOSIDE PHARMACOKINETICS

被引:11
作者
FAUVELLE, F
PERRIN, P
BELFAYOL, L
BOUKARI, M
CHERRIER, P
BOSIO, AM
TOD, M
COULAUD, JM
PETITJEAN, O
机构
[1] MONTFERMEIL HOSP,DEPT INTENS CARE MED,F-93370 MONTFERMEIL,FRANCE
[2] AVICENNE HOSP,DEPT PHARMACOTOXICOL,F-93009 BOBIGNY,FRANCE
关键词
D O I
10.1128/AAC.38.3.620
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Netilmicin (4.5 mg/kg of lean body weight) was administered intravenously once every 24 h at 10 a.m. to 23 patients (group I) and at 10 p.m. to 20 patients (group II) with severe infection. No significant differences (P > 0.05) in peak and trough concentrations in serum were found between groups I and II (peak, 12.9 +/- 3.7 versus 12.8 +/- 4.4 mg/liter, respectively; trough, 0.7 +/- 0.6 versus 0.8 +/- 0.6 mg/liter, respectively [mean +/- standard deviation]). Pharmacokinetic parameters (half-life [5.0 +/- 2.2 versus 4.9 +/- 1.8 hi, volume of distribution [0.32 +/- 0.04 versus 0.35 +/- 0.06 liter/kg], and total clearance [0.920 +/- 0.417 versus 1.015 +/- 0.546 ml/min/kg]) were similar in the two groups and not influenced by the time of administration. These data suggest that, in the once-daily schedule, 10 a.m. or 10 p.m. administration had no influence on netilmicin levels in serum and pharmacokinetic parameters in these ill febrile patients.
引用
收藏
页码:620 / 623
页数:4
相关论文
共 23 条
[1]   CLINICAL AND BACTERIOLOGICAL EFFICACY, AND PRACTICAL ASPECTS OF AMIKACIN GIVEN ONCE DAILY FOR SEVERE INFECTIONS [J].
BEAUCAIRE, G ;
LEROY, O ;
BEUSCART, C ;
KARP, P ;
CHIDIAC, C ;
CAILLAUX, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 :91-103
[2]   INFLUENCE OF DOSAGE REGIMEN ON EXPERIMENTAL GENTAMICIN-NEPHROTOXICITY - DISSOCIATION OF PEAK SERUM LEVELS FROM RENAL-FAILURE [J].
BENNETT, WM ;
PLAMP, CE ;
GILBERT, DN ;
PARKER, RA ;
PORTER, GA .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (04) :576-580
[3]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[4]   THE POSTANTIBIOTIC EFFECT [J].
CRAIG, WA ;
VOGELMAN, B .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) :900-902
[5]  
DORIAN C, 1985, PATHOL BIOL, V33, P377
[6]  
DORIAN C, 1990, 10TH INT M ANT INF C, P232
[7]   CIRCADIAN VARIATION IN SERUM AMIKACIN LEVELS [J].
ELTING, L ;
BODEY, GP ;
ROSENBAUM, B ;
FAINSTEIN, V .
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (09) :798-801
[8]   SAFETY, PHARMACOKINETICS AND EFFICACY OF ONCE-A-DAY NETILMICIN AND AMIKACIN VERSUS THEIR CONVENTIONAL SCHEDULES IN PATIENTS SUFFERING FROM PELVIC INFLAMMATORY DISEASE [J].
IBRAHIM, S ;
DERDE, MP ;
KAUFMAN, L ;
CLERCKXBRAUN, F ;
JACQMIN, P ;
BRULEIN, V ;
DONNEZ, J ;
TULKENS, PM .
RENAL FAILURE, 1990, 12 (03) :199-203
[9]   AMINOGLYCOSIDE TOXICITY - A REVIEW OF CLINICAL-STUDIES PUBLISHED BETWEEN 1975 AND 1982 [J].
KAHLMETER, G ;
DAHLAGER, JI .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 :9-22
[10]   CHRONOKINETIC STUDY OF NETILMICIN IN MAN [J].
LUCHT, F ;
TIGAUD, S ;
ESPOSITO, G ;
COUGNARD, J ;
FARGIER, MP ;
PEYRAMOND, D ;
BERTRAND, JL .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (02) :199-201